1266784-17-1

Basic information

• Product Name: (RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione
• Synonyms: (RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione
• CAS NO: 1266784-17-1
• Molecular Weight: 287.088
• Mol File: 1266784-17-1.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: (RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: (RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione(1266784-17-1)
• EPA Substance Registry System: (RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione(1266784-17-1)

Safety Data

• Hazardous Substances Data: 1266784-17-1(Hazardous Substances Data)

Usage

Description

(RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione is a chemical compound that belongs to the imidazolidine-2,4-dione family. It is characterized by a five-membered ring structure with a bromo and fluorophenyl group attached to it, along with a methyl group at the 5-position. These structural features make it a potential candidate for various pharmacological applications, including as a potential therapeutic agent for the treatment of certain medical conditions. Additionally, the compound may also have applications in the field of chemical synthesis and research due to its unique structure and properties. Overall, (RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione holds promise for further exploration and research in the biomedical and chemical fields.

Uses

Used in Pharmaceutical Applications:
(RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione is used as a potential therapeutic agent for the treatment of certain medical conditions due to its unique structural features and pharmacological properties.
Used in Chemical Synthesis and Research:
(RS)-5-(5-bromo-2-fluorophenyl)-5-methyl-imidazolidine-2,4-dione is used as a compound with potential applications in the field of chemical synthesis and research, given its unique structure and properties that may contribute to the development of new chemical processes and products.

Upstream product

• 910912-20-8 5-bromo-2-fluoro-N-methoxy-N-methylbenzamide 
• 146328-85-0 5-bromo-2-fluoro-benzoic acid 
• 198477-89-3 1-(5-bromo-2-fluorophenyl)ethan-1-one 
• 506-87-6 ammonium carbonate 

Downstream Products

• 1266784-13-7 rac-5-(5-bromo-2-fluorophenyl)-5-methylmorpholin-3-one 
• 1266784-18-2 rac-2-amino-2-(5-bromo-2-fluoro-phenyl)-propionic acid methyl ester 
• 1266784-23-9 (RS)-2-amino-2-(5-bromo-2-fluoro-phenyl)-propionic acid 
• 1266784-24-0 (RS)-2-amino-2-(5-bromo-2-fluoro-phenyl)-propan-1-ol 
• 1266784-29-5 rac-N-(2-(5-bromo-2-fluorophenyl)-1-hydroxypropan-2-yl)-2-chloroacetamide 
• 1266784-31-9 (RS)-5-[5-(benzhydrylidene-amino)-2-fluoro-phenyl]-5-methyl-morpholin-3-one 
• 1266784-38-6 (R)-(+)-N-[1-(5-bromo-2-fluoro-phenyl)-2-hydroxy-1-methyl-ethyl]-2-chloro-acetamide 
• 1266784-40-0 (S)-(-)-N-[1-(5-bromo-2-fluoro-phenyl)-2-hydroxy-1-methyl-ethyl]-2-chloro-acetamide 
• 1266785-76-5 N-[(RS)-1-(5-bromo-2-fluoro-phenyl)-2-hydroxy-1-methyl-ethyl]-3-phenyl-acrylamide 
• 1386998-17-9 (R)-5-[5-((RS)-3-chloro-6,7-dihydro-5H-[1]pyrindin-7-ylamino)-2-fluoro-phenyl]-5-methyl-morpholin-3-thione 
• 1386998-16-8 (R)-5-[5-((RS)-3-chloro-6,7-dihydro-5H-[1]pyrindin-7-ylamino)-2-fluoro-phenyl]-5-methyl-morpholin-3-one 
• 1386997-94-9 [3-((R)-5-amino-3-methyl-3,6-dihydro-2H-[1,4]oxazin-3-yl)-4-fluoro-phenyl]-(3-chloro-6,7-dihydro-5H-[1]pyrindin-7-yl)-amine 
• 1386998-19-1 (R)-5-{5-[(4-chloro-1-difluoromethyl-1H-pyrazol-3-ylmethyl)-amino]-2-fluoro-phenyl}-5-methyl-morpholine-3-thione 
• 1267800-39-4 (R)-5-(5-amino-2-fluoro-phenyl)-5-methyl-morpholin-3-one 

Relevant articles and documents

5-ARYL-1-IMINO-1-OXO-[1,2,4]THIADIAZINES

The present invention provides a compound of formula I' having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are

1,4 OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS

The present invention provides 1,4 Oxazines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present

1,4 OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS

The present invention relates to 1,4 Oxazines of formula (I): having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the pre